These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28098895)

  • 21. Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients.
    Wanram S; Klaewkla N; Pinyosri P
    Microrna; 2024; 13(1):56-62. PubMed ID: 38231064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
    Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
    Wang G; Gu J; Gao Y
    Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells.
    Xiang KM; Li XR
    Asian Pac J Cancer Prev; 2014; 15(8):3767-72. PubMed ID: 24870791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression.
    Liang HL; Hu AP; Li SL; Xie JP; Ma QZ; Liu JY
    Asian Pac J Cancer Prev; 2015; 16(6):2397-402. PubMed ID: 25824771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: significance of their regulation.
    Vicinus B; Rubie C; Stegmaier N; Frick VO; Kölsch K; Kauffels A; Ghadjar P; Wagner M; Glanemann M
    Oncol Rep; 2013 Sep; 30(3):1285-92. PubMed ID: 23817679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G; Wang R; Wang M
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer.
    Qin YZ; Xie XC; Liu HZ; Lai H; Qiu H; Ge LY
    Oncol Rep; 2015 Jun; 33(6):2728-36. PubMed ID: 25845814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
    Xiong B; Cheng Y; Ma L; Zhang C
    Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA‑133b inhibits connective tissue growth factor in colorectal cancer and correlates with the clinical stage of the disease.
    Guo Y; Li X; Lin C; Zhang Y; Hu G; Zhou J; Du J; Gao K; Gan Y; Deng H
    Mol Med Rep; 2015 Apr; 11(4):2805-12. PubMed ID: 25501363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.
    Song Y; Xu Y; Wang Z; Chen Y; Yue Z; Gao P; Xing C; Xu H
    Int J Cancer; 2012 Sep; 131(5):1042-51. PubMed ID: 22020560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.
    Sun D; Wang C; Long S; Ma Y; Guo Y; Huang Z; Chen X; Zhang C; Chen J; Zhang J
    Br J Cancer; 2015 Apr; 112(9):1491-500. PubMed ID: 25867276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
    Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
    Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
    Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-7 Is Associated with Malignant Potential and Poor Prognosis in Human Colorectal Cancer.
    Nagano Y; Toiyama Y; Okugawa Y; Imaoka H; Fujikawa H; Yasuda H; Yoshiyama S; Hiro J; Kobayashi M; Ohi M; Araki T; Inoue Y; Mohri Y; Kusunoki M
    Anticancer Res; 2016 Dec; 36(12):6521-6526. PubMed ID: 27919977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.